← Back to headlines
Pfizer and Zai Lab Secure China Approval for Cervical Cancer Therapy Tivdak
Pfizer and Zai Lab have received approval from Chinese authorities for Tivdak, their cervical cancer therapy, expanding its market reach.
9 Jun, 11:30 — 9 Jun, 11:30
Sources
Showing 1 of 1 sources
Related Stories
South Korea Central Bank Raises Rates to 3%, Upgrades Growth Forecast
32m ago
Meta Agrees to $17 Billion Settlement Over Teen Mental Health Lawsuits
1h ago
Nvidia in Talks to Acquire AI Platform Hugging Face for Over $13 Billion
1h ago
Mesoblast Reports Strong Revenue Growth Amid Commercial Transition
1h ago